➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: May 12, 2021

DrugPatentWatch Database Preview

Litigation Details for Janssen Products, L.P. v. Lupin Limited (Fed. Cir. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Janssen Products, L.P. v. Lupin Limited
The small molecule drugs covered by the patents cited in this case are   Get Started for $10 ,   Get Started for $10 , and   Get Started for $10 .

Details for Janssen Products, L.P. v. Lupin Limited (Fed. Cir. 2014)

Date Filed Document No. Description Snippet Link To Document
2015-01-22 34 5,843,946 (“the ‘946 patent”); 6,248,775 (“the ‘775 patent”); RE 6 “Janssen” as set forth herein refers to… disclosed. U.S. PATENT DOCUMENTS 6,248,775 Bl 612001 Vazquez et al. …5,843,946; 6,248,775; RE 42,889; and RE 43,596. (See Raghavan Aff. ¶ 3). Those disputes have been fully and …pharmaceutical formulations in improved stability and 6,248,775, and in Bioorganic and Chemistry Letters, Vol.…hydroxypropylcarbamate as well as intermediates for use in 6,248,775 Bl 6/2001 Vazquez et al. External link to document
2015-05-01 42 (A2536-52) Searle ‘775 U.S. Patent No. 6,248,775 B1 (A1632-746) …015 patent U.S. Patent No. 7,126,015 B2 (A371-95) ‘645 patent U.S. Patent No. … Janssen asserts ‘015 patent claim 1 and ‘645 patent claim 4. ‘015 patent claim 1 encompasses a… 645 Patent U.S Patent No 7126015 B2 the 015 Patent …Janssen asserted Lupin infringed ‘645 patent claim 4 and ‘015 patent claim 1; Lupin counterclaimed. 28 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.